Stenotrophomonas maltophilia is an aerobic, nonfermentative and Gram-negative bacterium regarded as global emerging MDRO in hospitalized or immunocompromised patients. S. maltophilia is not highly virulent pathogen, but it has the ability to colonize in human respiratory tract in hospitals responsible for crude mortality rates i.e. 14%-69% with bacteremia. Currently, no such alternative approaches for altering the sensitivity pattern of antimicrobials are available against MDROs, biofield treatment may be a new approach to alter the susceptibility pattern of S. maltophilia.
An Evaluation of Biofield Treatment on Susceptibility Pattern of Multidrug Resistant Stenotrophomonas maltophilia: An Emerging Global Opportunistic Pathogen